-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
NewAmsterdam Pharma Co N.V. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2023 to 2024.
- NewAmsterdam Pharma Co N.V. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was -$1K.
- NewAmsterdam Pharma Co N.V. annual Income Tax Expense (Benefit) for 2024 was -$1K, a 104% decline from 2023.
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)